Physician Agency and the Zero‐Markup Drug Policy in China: Evidence From a Structural Model
Health Economics · 2025
DOI: 10.1002/hec.70073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Economics, 2025. Verfasst von Qifan Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Meta Platforms Inc., Menlo Park, California, USA. Hauptthemen laut MEDLINE: Health Policy, Practice Patterns, Physicians', Prescription Drugs. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Peking University School of Economics Research Seed Grant, Fundamental Research Funds for the Central Universities, Peking University.
Abstract (Originalsprache)
This paper quantifies physician agency in China's prescription drug market by exploiting the structural shift created by the Zero‐Markup Drug Policy. We find that physicians' prescribing decisions are about three times more sensitive to the hospital's profit margin than to the retail price faced by patients. The study provides several key findings. First, government policy exerts a strong influence on drug prices. Second, branded drugs are generally preferred over generics and display lower price elasticity. Third, the policy accounts for more than half of the observed decline in average wholesale prices. Finally, while the policy improves patient welfare, it reduces pharmaceutical firms' sales and profits, and a partial restoration of drug markups could increase overall social welfare.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Meta Platforms Inc., Menlo Park, California, USA.
- Bank of Canada, Ottawa, Ontario, Canada.
- Peking University School of Economics, Beijing, China.
ORCID-Profile: Castiel Chen Zhuang
Förderung
- National Natural Science Foundation of China
- Peking University School of Economics Research Seed Grant
- Fundamental Research Funds for the Central Universities, Peking University
Zitieren
APA
Huang, Q., Lu, Z., & Zhuang, C. C. (2025). Physician Agency and the Zero‐Markup Drug Policy in China: Evidence From a Structural Model. Health Economics. https://doi.org/10.1002/hec.70073
Vancouver
Huang Q, Lu Z, Zhuang CC. Physician Agency and the Zero‐Markup Drug Policy in China: Evidence From a Structural Model. Health Economics. 2025. doi:10.1002/hec.70073
BibTeX
@article{Huang2025,
author = {Huang, Qifan and Lu, Zhentong and Zhuang, Castiel Chen},
title = {Physician Agency and the Zero‐Markup Drug Policy in China: Evidence From a Structural Model},
journal = {Health Economics},
year = {2025},
doi = {10.1002/hec.70073}
}
EUVIMED